Results 171 to 180 of about 214,982 (356)
The Inductions of Tyrosine Aminotransferase by Glucagon and Hydrocortisone
Vilmos Csányi+2 more
openalex +1 more source
The value of uACR. CKD, chronic kidney disease; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; uACR, urine albumin‐to‐creatinine ratio. Abstract The high disease burden and bidirectional relationship of chronic kidney disease (CKD), heart failure (HF) and other cardiovascular disease (CVD) necessitate the need for early ...
Biykem Bozkurt+2 more
wiley +1 more source
Mechanism for the Stimulation in vivo of Hepatic Gluconeogenesis by Glucagon [PDF]
John Williamson
openalex +1 more source
Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine
ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi+3 more
wiley +1 more source
ABSTRACT Aims Overactivity of the sympathetic nervous system is a common underlying mechanism in development and progression of several heart failure with preserved ejection fraction (HFpEF) comorbidities. Decreasing renal sympathetic nerve activity using catheter‐based renal denervation (RDN) systems have shown efficacy in treating resistant ...
David J. Lefer+6 more
wiley +1 more source
Low-Dose Glucagon to Prevent and Treat Exercise-Associated Hypoglycemia in Individuals With Type 1 Diabetes: A Systematic Review and Meta-analysis. [PDF]
Lundemose SB+4 more
europepmc +1 more source
Comparison of Glucagon and Epinephrine Effects in the Dog [PDF]
Ediz Z. Ezdinli, Joseph E. Sokal
openalex +1 more source
Abstract A better understanding of additional mechanisms of heart failure (HF) progression may allow a different and more complete phenotyping of the disease and identification of novel therapeutic targets. Persistent latent myocardial inflammation/immune activation in HF may represent an attempt to restore tissue homeostasis in the failing heart ...
Gabriele Fragasso+20 more
wiley +1 more source
Splanchnic and Leg Glucagon Metabolism in Healthy Individuals and Those With Type 1 Diabetes: First-in-Human Study Using [13C9,15N1]Glucagon. [PDF]
Ruchi FNU+8 more
europepmc +1 more source